Results 161 to 170 of about 3,627,754 (377)
825. Immunosuppressive Agent Use in Patients with Comorbid HIV and Inflammatory Bowel Disease
Travis J Hunt +2 more
openalex +1 more source
Using the convolutional neural network model VDLIN, Co7 is identified as a promising therapeutic candidate. Co7 demonstrates distinct advantages over MCB by effectively balancing anti‐inflammatory and immune‐stimulatory functions, making it a potential novel approach for immune modulation.
Xuefei Guo +6 more
wiley +1 more source
Immunosuppressive Agents In Uveitis – My Experience
Prof. Jyotirmay Biswas
doaj +1 more source
Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis. [PDF]
Jiang N +7 more
europepmc +1 more source
Validation of Tissue Microarrays for the Study of Immunosuppressive Agent-induced Nephrotoxicity
Beom Jin Lim +2 more
openalex +2 more sources
The S100A4/STAT3 axis promotes Rmrp transcription in AEC‐IIs and Rmrp expression in AEC‐II‐derived exosomes. Upon entry into AMs, Rmrp binds to and blocks the ubiquitination and degradation of ZFP36. Increased ZFP36 induced Pfkfb3 mRNA decay by binding to AREs in the 3′ UTR, curbing glycolysis and immune responses of AMs and aggravating SII and ...
Chengxi Liu +17 more
wiley +1 more source
Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes. [PDF]
Rai U, Senapati D, Arora MK.
europepmc +1 more source
Calhm6 drives M2 macrophage polarization via the Chp1‐Camk4‐Creb1 axis, suppressing inflammation through calcium‐dependent ectosomal delivery. Calhm6 deficiency enhances M1 responses, boosting bactericidal activity but exacerbating tissue damage. LPS/IFNγ upregulate Calhm6 via Irf1, while IL‐4/Stat6 inhibits it, balancing immune outcomes.
Yanlong Xin +14 more
wiley +1 more source
This study describes a T cell surface engineering strategy that integrates polymer materials with tumor immunology, aiming to achieve broad‐spectrum anti‐tumor applications of glycopolymer‐engineered T (G‐T) cells via non‐genetic modification. Glycopolymer engineering generally modulates immune‐tumor crosstalk through specific cell‐cell interactions ...
Lihua Yao +8 more
wiley +1 more source

